Carmen C. Solórzano

Author

Carmen C. Solórzano

Also Known As

C C Solorzano, C Solorzano, C. C. Solorzano, C. C. Solórzano, C. SOLORZANO, C. Solorzano, C.C. Solorzano, CARMEN SOLORZANO, Carmen C Solorzano, Carmen C Solórzano

349

Publications

13.8K

Citations

H-Index

167

Concepts

All Affiliations

Vanderbilt University Vanderbilt University Medical Center University of Miami Medical College of Wisconsin Emory University

About

Carmen C. Solórzano is an author at Vanderbilt University specializing in medicine, surgery, and endocrine surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	81	7.1K
2	Health Sciences	10	10	452
3	Engineering	7	7	216
4	Public Health	4	4	1.8K
5	Natural Sciences	3	3	107

Carmen C. Solórzano

146

Publications

12.4K

Citations

H-Index

Page 1

	Year	Citations
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, The Lancet EpidemiologyCancer EpidemiologyMedicineGlobal HealthEpidemiology Of Cancer	2020	1.8K
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism Scott M. Wilhelm, Tracy Wang, Daniel T. Ruan, JAMA Surgery	2016	1.2K
Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Christiane J. Bruns, Carmen C. Solórzano, Matthew T. Harbison, PubMed Endothelial CellsChemoprevention StrategyPathologyCell DeathLiver Metastasis	2000	501
Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: Which criterion is the most accurate? Denise M. Carneiro, Carmen C. Solórzano, Maria C Nader, Surgery Parathyroid HormoneParathyroid DiseaseEndocrine SurgerySurgeryParathyroid Gland	2003	359
Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice Mark Labow, David J. Shuster, Maria Zetterström, The Journal of Immunology	1997	331
Quick Intraoperative Parathyroid Hormone Assay: Surgical Adjunct to Allow Limited Parathyroidectomy, Improve Success Rate, and Predict Outcome George L. Irvin, Carmen C. Solórzano, Denise M. Carneiro World Journal of Surgery	2004	262
Nonfunctioning islet cell carcinoma of the pancreas: Survival results in a contemporary series of 163 patients Carmen C. Solórzano, Jeffrey E. Lee, Peter W. T. Pisters, Surgery Surgical OncologyPancreatic CancerContemporary SeriesMedicineIslet Cell Carcinoma	2001	258
Long-term survival after surgical management of neuroendocrine hepatic metastases Evan S. Glazer, Jennifer F. Tseng, Waddah B. Al‐Refaie, HPB Surgical OncologyHepatologyMedicineLiver PhysiologyHepatobiliary Tumor	2010	227
Establishing the clinical utility of autofluorescence spectroscopy for parathyroid detection Melanie A. McWade, Melinda E. Sanders, James T. Broome, Surgery MedicineSpectroscopyAutofluorescence SpectroscopyParathyroid HormoneParathyroid Disease	2015	191
Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cheryl H. Baker, Carmen C. Solórzano, Isaiah J. Fidler PubMed AngiogenesisPancreatic CancerChemoprevention StrategyMedicinePharmacology	2002	186

Page 1